Herpes Zoster Vaccine in the Long-Term Care Setting: A Clinical and Logistical Conundrum

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Katherine Montag Schafer, Shannon Reidt

Abstract

Advancing age is associated with an increased risk of herpes zoster (shingles) infection and latent effects such as postherpetic neuralgia. The herpes zoster vaccine is recommended in those 60 years of age and older and has been shown to prevent both the primary disease and associated complications. While this recommendation applies to those living in long-term care facilities, there is little clinical evidence to support use in this population. Additionally, there are logistical barriers that may complicate the use of the vaccine. The article examines the evidence for vaccinating residents in long-term care facilities and discusses logistical barriers to vaccination. Pharmacists and providers may consider life expectancy and other factors when evaluating which patients should receive the vaccination.

Citations

Mar 28, 2019·Current Medical Research and Opinion·Helen SenderovichMaheen Mujtaba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

JAMA : the Journal of the American Medical Association
Stephen Bernard Lambert
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
José Luis Merino Cañada
© 2021 Meta ULC. All rights reserved